Search Results - "CHUANRUI XU"

Refine Results
  1. 1

    β-Catenin signaling in hepatocellular carcinoma by Xu, Chuanrui, Xu, Zhong, Zhang, Yi, Evert, Matthias, Calvisi, Diego F, Chen, Xin

    Published in The Journal of clinical investigation (15-02-2022)
    “…Deregulated Wnt/β-catenin signaling is one of the main genetic alterations in human hepatocellular carcinoma (HCC). Comprehensive genomic analyses have…”
    Get full text
    Journal Article
  2. 2

    Bmal1 integrates mitochondrial metabolism and macrophage activation by Alexander, Ryan K, Liou, Yae-Huei, Knudsen, Nelson H, Starost, Kyle A, Xu, Chuanrui, Hyde, Alexander L, Liu, Sihao, Jacobi, David, Liao, Nan-Shih, Lee, Chih-Hao

    Published in eLife (12-05-2020)
    “…Metabolic pathways and inflammatory processes are under circadian regulation. Rhythmic immune cell recruitment is known to impact infection outcomes, but…”
    Get full text
    Journal Article
  3. 3

    Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway by Xiang, Ming, Liu, Tingting, Tian, Cheng, Ma, Kun, Gou, Jing, Huang, Rongrong, Li, Senlin, Li, Qing, Xu, Chuanrui, Li, Lei, Lee, Chih-Hao, Zhang, Yonghui

    Published in Pharmacological research (01-03-2022)
    “…Kinsenoside (KD) exhibits anti-inflammatory and immunosuppressive effects. Dendritic cells (DCs) are critical regulators of the pathologic inflammatory milieu…”
    Get full text
    Journal Article
  4. 4

    Bmi1 drives hepatocarcinogenesis by repressing the TGFβ2/SMAD signalling axis by Li, Bin, Chen, Yuyuan, Wang, Fei, Guo, Jun, Fu, Wen, Li, Min, Zheng, Qichang, Liu, Yong, Fan, Lingling, Li, Lei, Xu, Chuanrui

    Published in Oncogene (30-01-2020)
    “…Bmi1 is overexpressed in one-third of hepatocellular carcinoma (HCC) patients and acts as an oncogene in hepatocarcinogenesis. However, the underlying…”
    Get full text
    Journal Article
  5. 5

    Enhanced anti-tumor effect of liposomal Fasudil on hepatocellular carcinoma in vitro and in vivo by Zhao, Ying, Zhang, Yu, Vazirinejad Mehdiabad, Milad, Zhou, Ke, Chen, Yuyuan, Li, Lei, Guo, Jun, Xu, Chuanrui

    Published in PloS one (03-10-2019)
    “…Hepatocellular carcinoma (HCC) is one of the most malignant cancers and the treatment options for this disease are limited and generally not effective. ROCK…”
    Get full text
    Journal Article
  6. 6

    Integrating bulk and single‐cell RNA sequencing reveals cellular heterogeneity and immune infiltration in hepatocellular carcinoma by Wang, Tingjie, Dang, Ningxin, Tang, Guangbo, Li, Zihang, Li, Xiujuan, Shi, Bingyin, Xu, Zhong, Li, Lei, Yang, Xiaofei, Xu, Chuanrui, Ye, Kai

    Published in Molecular oncology (01-06-2022)
    “…Efficacy of immunotherapy in hepatocellular carcinoma (HCC) is blocked by its high degree of inter‐ and intra‐tumor heterogeneity and immunosuppressive tumor…”
    Get full text
    Journal Article
  7. 7

    MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene by Luo, Hongbo, Yang, Rui, Li, Chun, Tong, Yongqing, Fan, Lingling, Liu, Xiuheng, Xu, Chuanrui

    Published in Tumor biology (01-07-2017)
    “…MiR-139-5p has been reported to be overexpressed in many types of cancers, but its role in bladder cancer has not been elucidated yet. Here, we report that…”
    Get full text
    Journal Article
  8. 8

    Optimization of immunoturbidimetric assay system enhanced by β2-microglobulin latex by Hu, Mingjie, Xu, Chuanrui, Yan, Dandan, Gao, Le, Zhang, Hao

    Published in BIO web of conferences (2024)
    “…In this study, three-factor and three-level orthogonal experiment was used to optimize the detection system of clinical renal function marker β2-microglobulin…”
    Get full text
    Journal Article
  9. 9

    Nitric oxide-releasing micelles with intelligent targeting for enhanced anti-tumor effect of cisplatin in hypoxia by Chen, Yan, Fang, Lei, Zhou, Weixin, Chang, Jinghan, Zhang, Xiaojuan, He, Chuanchuan, Chen, Chen, Yan, Ruicong, Yan, Yakai, Lu, Yao, Xu, Chuanrui, Xiang, Guangya

    Published in Journal of nanobiotechnology (16-08-2021)
    “…Hypoxic tumor microenvironment (TME) promotes tumor metastasis and drug resistance, leading to low efficiency of cancer chemotherapy. The development of…”
    Get full text
    Journal Article
  10. 10

    Indian Hedgehog Regulates Intestinal Stem Cell Fate Through Epithelial−Mesenchymal Interactions During Development by Kosinski, Cynthia, Stange, Daniel E, Xu, Chuanrui, Chan, Annie Sy, Ho, Coral, Yuen, Siu Tsan, Mifflin, Randy C, Powell, Don W, Clevers, Hans, Leung, Suet Yi, Chen, Xin

    Published in Gastroenterology (New York, N.Y. 1943) (01-09-2010)
    “…Background & Aims Intestinal stem cells (ISCs) are regulated by the mesenchymal environment via physical interaction and diffusible factors. We examined the…”
    Get full text
    Journal Article
  11. 11

    Integrating cell interaction with transcription factors to obtain a robust gene panel for prognostic prediction and therapies in cholangiocarcinoma by Wang, Tingjie, Xu, Chuanrui, Xu, Dan, Yang, Xiaofei, Liu, Yaxin, Li, Xiujuan, Li, Zihang, Dang, Ningxin, Lv, Yi, Zhang, Zhijing, Li, Lei, Ye, Kai

    Published in Frontiers in genetics (30-11-2022)
    “…The efficacy of immunotherapy for cholangiocarcinoma (CCA) is blocked by a high degree of tumor heterogeneity. Cell communication contributes to heterogeneity…”
    Get full text
    Journal Article
  12. 12

    Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid in vitro and in vivo by Li, Weijie, Yan, Ruicong, Liu, Yong, He, Chuanchuan, Zhang, Xiaojuan, Lu, Yao, Khan, Muhammad Waseem, Xu, Chuanrui, Yang, Tan, Xiang, Guangya

    Published in Drug delivery (01-01-2019)
    “…Overexpression of Bmi1 gene is an important feature of cancer stem cell in various human tumors. Therefore, Bmi1 gene can be a potential target for small…”
    Get full text
    Journal Article
  13. 13

    Bmi1 is required for hepatic progenitor cell expansion and liver tumor development by Fan, Lingling, Xu, Chuanrui, Wang, Chunmei, Tao, Junyan, Ho, Coral, Jiang, Lijie, Gui, Bing, Huang, Shiang, Evert, Matthias, Calvisi, Diego F, Chen, Xin

    Published in PloS one (28-09-2012)
    “…Bmi1 is a polycomb group transcriptional repressor and it has been implicated in regulating self-renewal and proliferation of many types of stem or progenitor…”
    Get full text
    Journal Article
  14. 14

    Validation of Bmi1 as a therapeutic target of hepatocellular carcinoma in mice by Qi, Shibo, Li, Bin, Yang, Tan, Liu, Yong, Cao, Shanshan, He, Xingxing, Zhang, Peng, Li, Lei, Xu, Chuanrui

    “…Bmi1 is a member of the polycomb group family of proteins, and it drives the carcinogenesis of various cancers and governs the self-renewal of multiple types…”
    Get full text
    Journal Article
  15. 15

    RNA interference as therapeutics for hepatocellular carcinoma by Xu, Chuanrui, Lee, Susie A, Chen, Xin

    “…Hepatocellular carcinoma (HCC), a major form of primary liver cancer, is one of the leading causes of cancer related deaths worldwide. Hepatitis B and C…”
    Get more information
    Journal Article
  16. 16

    A novel chenodeoxycholic acid-verticinone ester induces apoptosis and cell cycle arrest in HepG2 cells by Liang, Dong, Zhou, Qing, Zhang, Jiuliang, Gong, Wei, Xu, Chuanrui, Li, Bin, Wang, Yi, Li, Jiangtao

    Published in Steroids (01-11-2012)
    “…► CDCA-Ver inhibited HepG2 cell viability and induced apoptotic cell death. ► CDCA-Ver induced G0/G1 cell cycle arrest. ► We concluded that CDCA-Ver may be a…”
    Get full text
    Journal Article
  17. 17

    Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells by XU, DONG, HE, XINGXING, CHANG, YING, XU, CHUANRUI, JIANG, XIANG, SUN, SHUZHEN, LIN, JUSHENG

    Published in Oncology reports (01-02-2013)
    “…microRNAs (miRNAs) are negative regulators of gene expression and can function as tumor suppressors or oncogenes. Several miRNAs are associated with the…”
    Get full text
    Journal Article
  18. 18

    Co-delivery of doxorubicin and Bmi1 siRNA by folate receptor targeted liposomes exhibits enhanced anti-tumor effects in vitro and in vivo by Yang, Tan, Li, Bin, Qi, Shibo, Liu, Yong, Gai, Yongkang, Ye, Peng, Yang, Guang, Zhang, Wendian, Zhang, Peng, He, Xingxing, Li, Weijie, Zhang, Zhiping, Xiang, Guangya, Xu, Chuanrui

    Published in Theranostics (2014)
    “…Bmi1 gene overexpression is found in various human tumors and has been shown as a potential target for gene treatment. However, siRNA-based treatments…”
    Get full text
    Journal Article
  19. 19

    Resveratrol Attenuates High-Fat Diet-Induced Hepatic Lipotoxicity by Upregulating Bmi-1 Expression by Yuan, Weigang, Zhang, Mi, Wang, Chunxu, Li, Bin, Li, Lei, Ye, Feng, Xu, Chuanrui

    “…Resveratrol (RES), a natural polyphenol phytoalexin, has been reported to attenuate nonalcoholic fatty liver disease (NAFLD). However, its roles on protection…”
    Get full text
    Journal Article
  20. 20

    Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression by Wang, Tingjie, Xu, Chuanrui, Zhang, Zhijing, Wu, Hua, Li, Xiujuan, Zhang, Yu, Deng, Nan, Dang, Ningxin, Tang, Guangbo, Yang, Xiaofei, Shi, Bingyin, Li, Zihang, Li, Lei, Ye, Kai

    Published in Hepatology (Baltimore, Md.) (01-11-2022)
    “…Background and Aims Intrahepatic cholangiocarcinoma (ICC) is not fully investigated, and how stromal cells contribute to ICC formation is poorly understood. We…”
    Get full text
    Journal Article